Goldman Sachs Group Inc Hille Vax, Inc. Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Hille Vax, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 41,614 shares of HLVX stock, worth $73,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,614

Holding current value

$73,240

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.86 - $15.93 $493,542 - $662,911	41,614 New	41,614 $601,000
Q4 2023 Feb 13, 2024	BUY	$10.35 - $17.11 $30,553 - $50,508	2,952 Added 17.0%	20,314 $326,000
Q3 2023 May 14, 2024	SELL	$11.59 - $16.7 $34,213 - $49,298	-2,952 Reduced 14.53%	17,362 $233,000
Q3 2023 Nov 14, 2023	SELL	$11.59 - $16.7 $155,955 - $224,715	-13,456 Reduced 43.66%	17,362 $233,000
Q2 2023 May 14, 2024	BUY	$12.93 - $18.76 $204,979 - $297,402	15,853 Added 105.93%	30,818 $529,000
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.76 $204,979 - $297,402	15,853 Added 105.93%	30,818 $529,000
Q1 2023 May 14, 2024	SELL	$14.73 - $18.18 $6,127 - $7,562	-416 Reduced 2.7%	14,965 $247,000
Q1 2023 May 11, 2023	SELL	$14.73 - $18.18 $6,127 - $7,562	-416 Reduced 2.7%	14,965 $247,000
Q4 2022 May 14, 2024	SELL	$13.52 - $21.46 $66,694 - $105,862	-4,933 Reduced 24.28%	15,381 $257,000
Q4 2022 Feb 13, 2023	BUY	$13.52 - $21.46 $207,951 - $330,076	15,381 New	15,381 $257,000

Others Institutions Holding HLVX

# of Institutions

Shares Held

40.5M

Call Options Held

Put Options Held

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.6M
Shares

$18.7 Million
9.05% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

4M
Shares

$7.05 Million
1.22% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.48M
Shares

$6.13 Million
0.03% of portfolio
Black Rock Inc. New York, NY

2.09M
Shares

$3.68 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

1.99M
Shares

$3.5 Million
0.01% of portfolio

View Full List

About HilleVax, Inc.

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $58.8M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

More about HLVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account